期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Discovery and Characterization of a Novel Method for Effective Improvement of Cyclodextrin Yield and Product Specificity
1
作者 HUA Jinghan ZHANG Hongbin +3 位作者 WU Hao WANG Jiadong HU Xueqin YANG Jingwen 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2019年第4期708-713,共6页
Cyclodextrins(CDs) are widely used in food,phamiaceuticals, drug delivery, and chemical industries and in agriculture and environmental engineering. To improve the yield and selectivity of CDs, this work presented a t... Cyclodextrins(CDs) are widely used in food,phamiaceuticals, drug delivery, and chemical industries and in agriculture and environmental engineering. To improve the yield and selectivity of CDs, this work presented a tacile, scalable and efficient enzymatic synthesis of β-CD from starch using β-cyclodextrin glycosyltransferase (CGTase, EC2.4.1.19) from Bacillus cereus. First, we found that the pretreatment of starch dramatically influenced CDs yield that was related to the structure and molecular weight of the substrate starch. Second, alcohol solvents influenced the yield and product selectivity of CDs;tertiary alcohols enhanced CDs yield(from 54.95% to 68.21%) and secondary alcohols increased the product selectivity(β-CD/γ-CD changed from 6.25 to 8.05). Fluorescence quenching analysis showed that the binding constants and entropy of the solvents influenced the yield and product selectivity, respectively. In conclusion, the results demonstrate that this study provides a promising method for the industrial production of β-CD. 展开更多
关键词 Β-CYCLODEXTRIN GLYCOSYLTRANSFERASE ALCOHOL solvent BACILLUS CEREUS CYCLODEXTRIN
原文传递
Discovery of novel aspartate derivatives as highly potent and selective FXIa inhibitors
2
作者 Ling Zhang Wei Chen +5 位作者 Ningning Yao Shuzeng Hou Zhiwei Meng Yi Kong Chenzhong Liao Zhouling Xie 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第10期727-737,共11页
As a coagulation factor in the intrinsic coagulation pathway,factor XIa(FXIa)is an effective and safe target for the development of antithrombotic drugs.Many small-molecule FXIa inhibitors have been discovered,some of... As a coagulation factor in the intrinsic coagulation pathway,factor XIa(FXIa)is an effective and safe target for the development of antithrombotic drugs.Many small-molecule FXIa inhibitors have been discovered,some of which are being evaluated in clinical trials.However,none of them have been approved.In the present study,a highly selective potent FXIa inhibitor with poor solubility reported in our previous work was selected as a lead compound to be further modified to improve FXIa potency and physicochemical properties.The structure-based drug design and structure-activity relationship study led to the discovery of LY8,LY17,and LY25,which demonstrated enhanced FXIa potency and maintained excellent selectivity.In addition,LY8 exhibited significantly improved aqueous solubility,suggesting that it could be a promising compound to be further evaluated. 展开更多
关键词 ANTITHROMBOSIS ANTICOAGULANTS Factor XIa Bleeding risk Structure-activity relationship
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部